The Length of Treatment Determines Whether IFN-β Prevents or Aggravates Experimental Autoimmune Encephalomyelitis in Lewis Rats

Journal of Immunology

Volumn 157, Issue 12, 1996, Pages 5721-5731

  Ruuls, Sigrid R ^a   De Labie, Miranda C D C ^b   Weber, Kimberley S ^a   Botman, Carolien A D ^b   Groenestein, Reno J ^b   Dijkstra, Christine D ^a   Olsson, Tomas ^c   Van Der Meide, Peter H ^b  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA INTERFERON; CORTICOSTERONE; GAMMA INTERFERON; MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL; ARTICLE; BIOSYNTHESIS; BODY WEIGHT; DOSE RESPONSE; DRUG ADMINISTRATION; IMMUNOLOGY; LEWIS RAT; LYMPHOID TISSUE; PATHOLOGY; PATHOPHYSIOLOGY; RAT; SPINAL CORD; TIME;

ANIMALS; AUTOANTIBODIES; BODY WEIGHT; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERFERON TYPE II; INTERFERON-BETA; LYMPHOID TISSUE; MYELIN BASIC PROTEINS; RATS; RATS, INBRED LEW; SPINAL CORD; TIME FACTORS;

EID: 0030589314     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. The Interferon-β Multiple Sclerosis Study Group. 1993. Interferon beta-IB is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:655.
2. Paty, D. W., D. K. B. Li, the MS/MRI Study Group, and the Interferon-β Multiple Sclerosis Study Group. 1993. Interferon beta-IB is effective in relapsing-remitting multiple sclerosis. II. MRI analysts results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:662.
3. Lu, H. T., J. L. Riley, G. T. Babcock, M. Huston, G. R. Stark, J. M. Boss, and R. M. Ransohoff. 1995. Interferon (IFN) β acts downstream of IFN-γ-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-γ. J. Exp. Med. 182:1517.
4. Barna, B. P., S. M. Chou, B. Jacobs, B. Yen-Lieberman, and R. M. Ransohoff. 1989. Interferon-β impairs induction of HLA-DR antigen expression in cultured adult human astrocytes. J. Neuroimmunol. 23:45.
5. Inaba, K., M. Kitaura, T. Kato, Y. Watanabe, Y. Kawade, and S. Muramatsu. 1986. Contrasting effect of α/β and γ-interferons on expression of macrophage Ia antigens. J. Exp. Med. 163:1030.
6. Yoshida, R., H. W. Murray, and C. F. Nathan. 1988. Agonist and antagonist effects of interferon α and β on activation of human macrophages. J. Exp. Med. 167:1171.
7. Garotta, G., K. W. Talmadge, J. R. Pink, B. Dewald, and M. Baggiolini. 1986. Functional antagonism between type I and type II interferons on human macrophages. Biochem. Biophys. Res. Commun. 140:948.
8. Borden, E. C. 1992. Interferons: pleiotropic cellular modulators. Clin. Immunol. Immunopathol. 62:518.
9. Ghiara, P., M. Bartalini, A. Tagliabue, and D. Boraschi. 1986. Anti-inflammatory activity of IFN-β in carrageenan-induced pleurisy in the mouse. Clin. Exp. Immunol. 66:606.
10. Ransohoff, R. M., T. A. Hamilton, M. Tani, M. H. Stoler, H. E. Schick, J. A. Major, M. L. Estes, D. M. Thomas, and V. K. Tuohy. 1993. Astrocyte expression of mRNA encoding cytokines IP-10 and JE-MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7:592.
11. Nolten, W. E., D. Goldstein, M. Lindstrom, M. V. McKenna, I. H. Carlson, D. L. Trump, J. Schiller, E. C. Borden, and E. N. Ehrlich. 1993. Effects of cytokines on the pituitary-adrenal axis in cancer patients. J. Interferon Res. 13:349.
12. Akahoshi, T., J. J. Oppenheim, and K. Matsushima. 1988. Induction of high-affinity interleukin 1 receptor on human peripheral blood lymphocytes by glucocorticoid hormones. J. Exp. Med. 167:924.
13. Fantuzzi, G., E. DiSanto, S. Sacco, F. Benigni, and P. Ghezzi. 1995. Role of the hypothalamus-pituitary-adrenal axis in the regulation of TNF production in mice: effect of stress and inhibition of endogenous glucocorticoids. J. Immunol. 155: 3552.
14. Arya, S. K., F. Wong-Staal, and R. C. Gallo. 1984. Dexamethasone-mediated inhibition of human T cell growth factor and γ-interferon messenger RNA. J. Immunol. 133:273.
15. Van der Meide, P. H., A. M. Joosten, P. Hermans, T. C. Kloosterman, T. Olsson, and M. C. D. C. de Labie. 1991. Assessment of the inhibitory effect of immunosuppressive agents on rat T cell interferon-γ production using an ELISPOT assay. J. Immunol. Methods 144:203.
16. Vartanian, T., Y. Li, M. Zhao, and K. Stefansson. 1995. Interferon-γ-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol. Med. 1:732.
17. Lipton, M. M., and J. Freund. 1953. Allergic encephalomyelitis in the rat induced by the intracutaneous injection of central nervous system tissue and adjuvants. J. Immunol. 71:98.
18. Mannie, M. D., P. Y. Paterson, D. C. U'Prichard, and G. Flouret. 1985. Induction of experimental allergic encephalomyelitis in Lewis rats with purified synthetic peptides: delineation of antigenic determinants for encephalitogenicity, in vitro activation of cellular transfer, and proliferation of lymphocytes. Proc. Natl. Acad. Sci. USA 82:5515.
19. Alvord, E. C., Jr. 1984. The challenge: how good a model of MS is EAE today? Prog. Clin. Biol. Res. 146:3.
20. Abreu, S. L. 1982. Suppression of experimental allergic encephalomyelitis by interferon. Immunol. Commun. 11:1.
21. Abreu, S. L. 1985. Interferon in experimental autoimmune encephalomyelitis (EAE): effects of exogenous interferon on the antigen-enhanced adoptive transfer of EAE. Int. Arch. Allergy Appl. Immunol. 76:302.
22. Higashi, Y., Y. Sokawa, Y. Watanabe, Y. Kawade, S. Ohno, C. Takaoka, and T. Taniguchi. 1983. Structure and expression of a cloned cDNA for mouse interferon-β J. Biol. Chem. 258:9522.
23. Dijkema, R., P. H. van der Meide, P. H. Pouwels, M. Caspers, M. Dubbeld, and H. Schellekens. 1985. Cloning and expression of the chromosomal immune interferon gene of the rat. EMBO J. 4:761.
24. Dijkstra, C. D., E. A. Dopp, P. Joling, and G. Kraal. 1985. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 54:589.
25. Van der Meide, P. H., M. C. D. C. de Labie, C. A. D. Botman, W. P. van Bennekom, T. Olsson, J. Aten, and J. J. Weening. 1993. Mercuric chloride downregulates T cell interferon-γ production in Brown Norway but not in Lewis rats; role of glutathione. Eur. J. Immunol. 23:675.
26. Mason, D. 1991. Genetic variation in the stress response: susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory disease. Immunol. Today 12:57.
27. Reder, A. T., and M. T. Lowy. 1992. Interferon-β treatment does not elevate cortisol in multiple sclerosis. J. Interferon Res. 12:195.
28. Panitch, H. S. 1992. Interferons in multiple sclerosis: a review of the evidence. Drugs 44:946.
29. Daynes, R. A., and B. A. Araneo. 1989. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur. J. Immunol. 19:2319.
30. Khoury, S. J., W. W. Hancock, and H. L. Weiner. 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176:1355.
31. Street, N. E., and T. R. Mosmann. 1991. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 5:171.
32. Snapper, C. M., and W. E. Paul. 1987. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944.
33. Brüggemann, M., C. Teale, M. Clark, C. Bindon, and H. Waldmann. 1989. A matched set of rat/mouse chimeric antibodies. Identification and biological properties of rat H chain constant regions mu, gamma 1, gamma 2a, gamma 2b, gamma 2c, epsilon, and alpha. J. Immunol. 142:3145.
34. Finkelman, F. D., A. Svetic, I. Gresser, C. Snapper, J. Holmes, P. P. Trotta, I. M. Katona, and W. C. Gause. 1991. Regulation by interferon α of immunoglobulin isotype selection and lymphokine production in mice. J Exp. Med. 174:1179.
35. H2 human T cell clones. J. Immunol. 149:2977.
36. Boham, C. A., and A. W. Thompson. 1995. Anti-inflammatory agents in allergic diseases. Clin. Exp. Immunol. 102:1.
37. Guyre, P. M., M. T. Girard, P. M. Morganelli, and P. D. Manganiello. 1988. Glucocorticoid effects on the production and actions of immune cytokines. J. Steroid Biochem. 30:89.
38. Probert, L., K. Akassoglou, M. Pasparakis, G. Kontogeorgos, and G. Kollias. 1995. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor α. Proc. Natl. Acad. Sci. USA 92:11294.
39. Selmaj, K., and C. S. Raine. 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:339.
40. Selmaj, K., C. S. Raine, M. Farooq, W. T. Norton, and C. F. Brosnan. 1991. Cytokine cytotoxicity against oligodendrocytes: apoptosis induced by lymphotoxin. J. Immunol. 147:1522.
41. + T cell lines in vitro. J. Immunol. 145:2474.
42. Male, D., G. Pryce, C. Hughes, and P. Lantos. 1990. Lymphocyte migration into brain modelled in vitro: controlled by lymphocyte activation, cytokines and antigen. Cell. Immunol. 127:1.
43. Issekutz, T. B., J. M. Stoltz, and P. H. van der Meide. 1988. Lymphocyte recruitment in delayed-type hypersensitivity: the role of IFN-γ. J. Immunol. 140: 2989.
44. Pober, J. S., M. A. Gimbrone, L. A. Lapierre, D. L. Mendrick, W. Fiers, R. Rothlein, and T. A. Springer. 1986. Overlapping patterns of activation of human endothelial cells by interleukin-1, tumor necrosis factor and immune interferon. J. Immunol. 137:1893.
45. Mustafa, M. I., P. Diener, B. Höjeberg, P. H. van der Meide, and T. Olsson. 1991. T cell immunity and interferon-γ secretion during experimental allergic encephalomyelitis in Lewis rats. J. Neuroimmunol. 31:165.
46. Olsson, T., W. W. Zhi, B. Höjeberg, V. Kostulas, J. Yu-Ring, G. Anderson, H.-P. Ekre, and H. Link. 1990. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-γ. J. Clin. Invest. 86:981.
47. Panitch, H. S., R. L. Hirsch, J. Schindler, and K. P. Johnson. 1987. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37:1097.
48. Noronha, A., A. Toscas, and M. A. Jensen. 1993. Interferon β decreases T cell activation and interferon γ production in multiple sclerosis. J. Neuroimmunol. 46:145.
49. Rudick, R. A., C. S. Carpenter, D. L. Cookfair, V. K. Tuohy, and R. M. Ransohoff. 1993. In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta. Neurology 43:2080.
50. Fertsch-Ruggio, D., D. R. Schoenberg, and S. N. Vogel. 1988. Induction of macrophage I-a antigen expression by rIFN-γ and downregulation by IFN-αβ and dexamethasone are regulated transcriptionally. J. Immunol. 141:1582.
51. 1 integrin. Nature 356:63.
52. 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:57.
53. Svenningsson, A., G. Hansson, O. Andersen, R. Andersson, M. Pataroyo, and S. Stemme. 1993. Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence from common recruitment mechanisms in multiple sclerosis, aseptic meningitis and normal controls. Ann. Neurol. 34:155.
54. Soilu-Hänninen, M., A. Salmi, and R. Salonen. 1995. Interferon-β downregulates expression of VLA-4 antigen and antagonizes interferon-γ-induced expression of HLA-DQ on human peripheral blood monocytes. J. Neuroimmunol. 60:99.
55. Stone, L. A., J. A. Frank, P. S. Albert, C. Bash, M. E. Smith, H. Maloni, and H. F. MacFarland. 1995. The effect of interferon-β on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis. Ann. Neurol. 37:611.
56. Bottomley, J. M., and J. L. Toy. 1985. Clinical side effects and toxicities of interferon. In Interferon 4: In Vivo and Clinical Studies. N. B. Finter and R. K. Oldham, eds. Elsevier Science Publishers, Amsterdam, The Netherlands, p. 155.
57. Sherwin, S. A., J. A. Knost, S. Fein, P. G. Abrams, K. A. Foon, J. J. Ochs, C. Schoenberger, A. E. Maluish, and R. K. Oldham. 1982. A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients. JAMA 248:2461.
58. Keller, R., R. Keist, H. Bazin, P. Joller, and P. H. van der Meide. 1990. Binding of monomeric immunoglobulins by bone marrow-derived mononuclear phagocytes: its modulation by interferon-γ. Eur. J. Immunol. 20:2137.
59. 2b on rat macrophages. Immunology 62:69.
60. Gausas, J., P. Y. Paterson, E. D. Day, and M. C. Dal Canto. 1982. Intact B cell activity is essential for complete expression of EAE in Lewis rats. Cell. Immunol. 72:360.
61. Willenborg, D. O., and S. J. Prowse. 1983. Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis. J. Neuroimmunol. 5:99.
62. Porrini, A. M., D. Gambi, and A. T. Reder. 1995. Interferon effects on interleukin-10 secretion: mononuclear cell response to interteukin-10 is normal in multiple sclerosis patients. J. Neuroimmunol. 61:27.
63. Levy, Y., and J. C. Brouet. 1994. Interleukin 10 prevents spontaneous death of germinal center B cells by induction of the Bcl-2 protein. J. Clin. Invest. 93:424.
64. Milanese, C., A. Salmaggi, L. La Mantia, A. Campi, M. Eoli, M. Savoiardo, G. Bianchi, and A. Nespolo. 1990. Double blind study of intrathecal beta-interferon in multiple sclerosis: clinical and laboratory results. J. Neurol. Neurosurg. Psychiatry 53:554.